Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial Comparing Intensity Modulated Radiotherapy With Integrated Boost to Conventional Radiotherapy With Consecutive Boost in Patients With Breast Cancer After Breast Conserving Surgery

NCT01322854 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01322854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial Comparing Intensity Modulated Radiotherapy With Integrated Boost to Conventional Radiotherapy With Consecutive Boost in Patients With Breast Cancer After Breast Conserving Surgery
Lead sponsor
Heidelberg University
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2011
Completion date
March 31, 2018
Enrollment
502 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer